Back to Search
MATTHEW HARBISON, MD
MD
Hospitalist Physician
NPI: 1043223209Individual
Specialties, Licenses & Credentials
Research & Publications (11)
Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia.
PMID 15797962·J Clin Endocrinol Metab·2005
3-trial
A randomized crossover study to evaluate Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinence.
PMID 14678373·BJU Int·2004
3-trial
Haplotype analysis of the growth hormone releasing hormone receptor locus in three apparently unrelated kindreds from the indian subcontinent with the identical mutation in the GHRH receptor.
PMID 12794696·Am J Med Genet A·2003
8-other
Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts.
PMID 12516957·Mol Cancer Ther·2002
7-preclinical
Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice.
PMID 12385004·Int J Cancer·2002
7-preclinical
Meier-Gorlin syndrome: report of eight additional cases and review.
PMID 11477602·Am J Med Genet·2001
5-case
Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.
PMID 11297576·J Clin Endocrinol Metab·2001
8-other
Osteoporosis: an unusual presentation of childhood Crohn's disease.
PMID 10852438·J Clin Endocrinol Metab·2000
5-case
Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma.
PMID 10850439·Cancer Res·2000
7-preclinical
Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.
PMID 10815919·Clin Cancer Res·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 6431 FANNIN ST, MSB 1.122
HOUSTON, TX 77030 - Phone
- (713) 500-6714
Quick Facts
- NPI
- 1043223209
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 4
- Locations
- 3
- Publications
- 11
Are you this provider?
Claim Your Profile